{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:33:13Z","timestamp":1779348793247,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bbmt.2020.04.023","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T03:57:31Z","timestamp":1588219051000},"page":"1303-1311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host Disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Chiara","family":"Frairia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Nicolosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jongphil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Betts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo F.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick L.","family":"Locke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asmita","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiga","family":"Nishihori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Leonel","family":"Ochoa-Bayona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Pidala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Anasetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2020.04.023_bib0001","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.bbmt.2003.12.304","article-title":"Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"10","author":"Martin","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0002","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1701899","article-title":"Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. International Bone Marrow Transplant Registry","volume":"24","author":"Martino","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0003","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0004","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200363010-00001","article-title":"Intestinal graft-versus-host disease: mechanisms and management","volume":"63","author":"Takatsuka","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0006","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1182\/blood-2005-12-4851","article-title":"Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day 5 responders and no advantage for nonresponders receiving anti-thymocyte globulin","volume":"107","author":"Van Lint","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0007","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.V76.8.1464.1464","article-title":"A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment","volume":"76","author":"Martin","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0008","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.seminhematol.2005.09.007","article-title":"Prophylaxis and treatment of acute graft-versus-host disease","volume":"43","author":"Chao","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0009","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.2174\/138161208785061436","article-title":"Novel drugs for the prevention and treatment of acute GVHD","volume":"14","author":"Cutler","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/14728210903018891","article-title":"Emerging drugs for acute graft-versus-host disease","volume":"14","author":"Khaled","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0011","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MOH.0b013e32834b6196","article-title":"Have we improved in preventing and treating acute graft-versus-host disease?","volume":"18","author":"Perez","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0012","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1517\/13543784.16.10.1709","article-title":"Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation","volume":"16","author":"McDonald","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0013","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.addr.2004.08.009","article-title":"Targeted delivery, safety, and efficacy of oral enteric-coated formulations of budesonide","volume":"57","author":"Fedorak","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0014","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.crohns.2010.07.003","article-title":"Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU study","volume":"4","author":"Nunes","year":"2010","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0015","first-page":"PI29","article-title":"Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study","volume":"12","author":"Tursi","year":"2006","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0016","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0016-5085(98)70254-9","article-title":"Budesonide versus prednisone in the treatment of active Crohn's disease. the Israeli Budesonide Study Group","volume":"115","author":"Bar-Meir","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0017","first-page":"445","article-title":"Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group","volume":"44","author":"Caesar","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0018","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1182\/blood-2006-05-021139","article-title":"A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease","volume":"109","author":"Hockenbery","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0019","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0016-5085(98)70361-0","article-title":"Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial","volume":"115","author":"McDonald","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/bbmt.2002.v8.pm12171485","article-title":"Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems","volume":"8","author":"MacMillan","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0021","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.bmt.1702055","article-title":"Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD","volume":"24","author":"Bertz","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0022","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/bmt.2013.107","article-title":"Prophylaxis and treatment of GVHD: EBMT-ELN Working Group recommendations for a standardized practice","volume":"49","author":"Ruutu","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0023","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00007890-199512000-00010","article-title":"Oral beclomethasone dipropionate for treatment of human intestinal graft-versus-host disease","volume":"60","author":"Baehr","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0024","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbmt.2006.05.010","article-title":"Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD)","volume":"12","author":"Castilla","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0025","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbmt.2005.04.008","article-title":"Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease","volume":"11","author":"Iyer","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0026","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/sj.bmt.1705489","article-title":"Oral beclomethasone dipropionate as an initial treatment of gastrointestinal acute graft-versus-host disease after reduced-intensity cord blood transplantation","volume":"38","author":"Miura","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0027","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2169\/internalmedicine.53.1858","article-title":"The use of oral beclomethasone dipropionate in the treatment of gastrointestinal graft-versus-host disease: the experience of the Fukuoka Blood and Marrow Transplantation (BMT) group","volume":"53","author":"Takashima","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0028","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/bmt.2008.209","article-title":"Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD","volume":"42","author":"Andree","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0029","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3324\/haematol.2017.182550","article-title":"Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated","volume":"103","author":"Nikiforow","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/sj.bmt.1701613","article-title":"Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation","volume":"23","author":"Wakui","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0031","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood.V76.3.624.624","article-title":"Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy","volume":"76","author":"Weisdorf","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0032","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00007890-198612000-00006","article-title":"A prospective study of unexplained nausea and vomiting after marrow transplantation","volume":"42","author":"Spencer","year":"1986","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0033","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, I: Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0034","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bbmt.2015.01.001","article-title":"A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality","volume":"21","author":"MacMillan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0035","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2141.2012.09114.x","article-title":"What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score","volume":"157","author":"MacMillan","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0036","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1182\/blood.2019003125","article-title":"Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial","volume":"135","author":"Pidala","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0037","doi-asserted-by":"crossref","unstructured":"Przepiorka D., Luo L., Subramaniam S., et al. FDA approval summary: Ruxolitinib for treatment of steroid-refractory acute graft-versus-host disease [e-pub ahead of print]. Oncologist. doi: 10.1634\/theoncologist.2019-0627.","DOI":"10.1634\/theoncologist.2019-0627"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0038","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0039","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s41409-019-0453-0","article-title":"The new refined Minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide","volume":"54","author":"Mariotti","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.04.023_bib0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/17474086.2017.1318054","article-title":"Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand","volume":"10","author":"Mussetti","year":"2017","journal-title":"Expert Rev Hematol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120302342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120302342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:11:28Z","timestamp":1761059488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879120302342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1083879120302342"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.04.023","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host Disease","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}